---

Related Articles:

Effect of lomeguatrib-temozolomide combination on MGMT promoter methylation and expression in primary glioblastoma tumor cells.

2013-06-01

[Tumour Biol. 34(3) , 1935-47, (2013)]

Randomized trial of the combination of lomeguatrib and temozolomide compared with temozolomide alone in chemotherapy naive patients with metastatic cutaneous melanoma.

2007-06-20

[J. Clin. Oncol. 25(18) , 2540-5, (2007)]

Inhibition of DNA repair with MGMT pseudosubstrates: phase I study of lomeguatrib in combination with dacarbazine in patients with advanced melanoma and other solid tumours.

2011-09-06

[Br. J. Cancer 105(6) , 773-7, (2011)]

Novel role of triazenes in haematological malignancies: pilot study of Temozolomide, Lomeguatrib and IL-2 in the chemo-immunotherapy of acute leukaemia.

2007-08-01

[DNA Repair (Amst.) 6(8) , 1179-86, (2007)]

A phase II trial of lomeguatrib and temozolomide in metastatic colorectal cancer.

2008-05-20

[Br. J. Cancer 98(10) , 1614-8, (2008)]